The Cilastatin project arose thanks to the research carried out by the deceased Dr. Alberto Tejedor, who was Nephrology Service section chief at the Gregorio Marañón General University Hospital and ...
Read moreThe biopharmaceutical company Ability Pharmaceuticals, SL today announced the inclusion of the first patients in a phase 2b clinical trial with its novel autophagy-inducer anticancer compound ABTL0812...
Read moreInvestHorizon is a programme financed by the European Commission, in association with Eureka, to facilitate series A funding for selected deep tech companies boosting their investment readiness and...
Read moreEl diagnóstico precoz y la mejora de los tratamientos del cáncer de mama han permitido disminuir su mortalidad en los últimos años, llegándose a situar los índices de supervivencia en el 85% a d...
Read moreAmunt Contra el Cáncer ha firmado un convenio de colaboración con el Instituto de Investigación Sanitaria INCLIVA, del Hospital Clínico de Valencia, en virtud del cual esta asociación, de mome...
Read moreYsios Capital, Spain’s largest and leading European venture capital firm specialised in the biotechnology sector, announces today that it has closed its third fund, Ysios BioFund III (YBF III) at...
Read moreGiven by the CRIS Cancer Foundation, this award seeks to promote and consolidate the careers of outstanding researchers in Spain by providing a grant of €1,250,000 per candidate over 5 years.
Read moreEl tratamiento se basa en las llamadas células TIL (Tumour-infiltrating Lymphocytes), linfocitos (células inmunitarias) que reconocen neoantígenos, es decir, células que se encuentran en el tumor ...
Read moreThe Barcelona Science Park from the Universitat de Barcelona (UB), and the Barcelona City Council are launching BCN Health Booster, an acceleration programme to boost start-ups with an innovative h...
Read moreEl director general de Galacteum asegura que, tras fuertes inversiones, la compañía prevé entrar en beneficios este año.
Read moreThe Transnational Access Committee of the European Advanced infraStructure for Innovative Genomics (EASI-Genomics) has selected the project PID15251 submitted by DBGen Ocular Genomics in the third ...
Read moreHere is a small sample of the news of the last year of some of the startups of the BioRegion that, in some cases, will be presented during the event. Don't miss them!
Read more